| Bonnie Ramsey | QAU145 ENAC Study Task Order #3 | Novartis Pharmaceuticals Corporation | $10,000 | 10/31/05 |
| David Suskind | Maternal Microchimerism in Inflammatory Bowel Disease | Broad (Eli and Edythe L.) Foundation | $142,178 | 10/25/05 |
| Ghassan Wahbeh | Multi-Center, Double-Blind Study of COLAZAL in the Treatment of 5- to 17-year Old Pediatric Subjects with Mild to Moderate Active Ulcerative Colitis | Salix Pharmaceuticals, Inc. | $133,100 | 10/21/05 |
| Bonnie Ramsey | Consulting Services Agreement | Berna Biotech | $10,747 | 10/21/05 |
| Janet Englund | Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Immunogenicity of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), in Children with Hemodynamically Significant Congenital Heart Disease | PPD, Inc. | $45,213 | 10/20/05 |